Clinical Trials for Edgewise Therapeutics

Explore 8 clinical trials worldwide

Showing 1-8 of 8 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Edgewise Therapeutics

Clinical Trials (8)

NCT07177066
A Study of EDG-15400 in Healthy Adults
PHASE1Recruiting
108 participants
Started: Aug 20, 2025 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT07034768
A Study to Evaluate EDG-7500 in People With Renal Impairment
PHASE1Recruiting
48 participants
Started: Jul 22, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT06347159
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
PHASE2Recruiting
75 participants
Started: Apr 11, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor18 locations
NCT06100887
Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy
PHASE2Active, not recruiting
43 participants
Started: Mar 22, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor7 locations
NCT06066580
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
PHASE2Enrolling by invitation
260 participants
Started: Nov 2, 2023 · Completed: Aug 31, 2029
1 condition2 sponsors46 locations
NCT05540860
A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)
PHASE2Active, not recruiting
76 participants
Started: Oct 24, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor14 locations
NCT05291091
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
PHASE2Active, not recruiting
175 participants
Started: Jul 6, 2022 · Completed: Aug 31, 2026
1 condition4 sponsors51 locations
NCT05257473
Defining Endpoints in Becker Muscular Dystrophy
N/AActive, not recruiting
80 participants
Started: Apr 13, 2022 · Completed: May 31, 2026
4 conditions2 sponsors11 locations